| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Umberger Traci S | General Counsel and Chief Administrative Officer, Director | C/O KESTRA MEDICAL TECHNOLOGIES, LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND | /s/ Traci S. Umberger | 31 Dec 2025 | 0001877198 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KMTS | Common Shares | Sale | $280,201 | -10,500 | -7.1% | $26.69 | 136,633 | 29 Dec 2025 | Direct | F1, F2, F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2025. |
| F2 | The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.51 to $26.96. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. |
| F3 | Includes 12,797 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9. |
General Counsel and Chief Administrative Officer